SEC Company Response from Annovis Bio, Inc. (ANVS) (CIK 0001477845) (ANVS) — Jan 24, 2020
Annovis Bio, Inc. (ANVS) (CIK 0001477845)
Date: Jan. 24, 2020 · CIK: 0001477845 · Accession: 0001104659-20-006737
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-232529
Letter
ANNOVIS BIO, INC.
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312
January 24, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention:
Office of Healthcare & Insurance
Re:
Annovis Bio
Registration Statement on Form S-1
Filed July 2, 2019
File No. 333-232529
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Annovis Bio, Inc., a Delaware corporation (the “Registrant”), hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-232529), as amended (the “Registration Statement”), so that it may become effective at 4:30 p.m. EST on Tuesday, January 28, 2020 or as soon thereafter as practicable.
The Registrant hereby acknowledges that:
(i) should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;
(ii) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and
(iii) the Registrant may not assert the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Please contact Darrick M. Mix of Duane Morris LLP, counsel to the Company, at (215) 979-1206, as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter.
Very truly yours,
ANNOVIS BIO, INC.
Show Raw Text
CORRESP 1 filename1.htm ANNOVIS BIO, INC. 1055 Westlakes Drive, Suite 300 Berwyn, PA 19312 January 24, 2020 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Office of Healthcare & Insurance Re: Annovis Bio Registration Statement on Form S-1 Filed July 2, 2019 File No. 333-232529 Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Annovis Bio, Inc., a Delaware corporation (the “Registrant”), hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-232529), as amended (the “Registration Statement”), so that it may become effective at 4:30 p.m. EST on Tuesday, January 28, 2020 or as soon thereafter as practicable. The Registrant hereby acknowledges that: (i) should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement; (ii) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and (iii) the Registrant may not assert the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Please contact Darrick M. Mix of Duane Morris LLP, counsel to the Company, at (215) 979-1206, as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter. Very truly yours, ANNOVIS BIO, INC. By: /s/ Maria Maccecchini Name: Maria Maccecchini Title: President and Chief Executive Officer 2